Skip to main content
Premium Trial:

Request an Annual Quote

Centogene CentoCancer and CentoCard

Centogene has launched CentoCancer and CentoCard. CentoCancer is a 31 gene panel that identifies an elevated risk of significant hereditary cancers including breast, ovarian, gastric, colon, endometrial, prostate, pancreatic, renal, liver, and skin cancer. CentoCard is a sample collection system that can be used to extract high-quality DNA to perform any genetic test, the company said. Once samples are dry, they are considered stable and can be mailed through regular post without special declaration.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.